This is a news story, published by Yahoo Finance, that relates primarily to Canaccord news.
For more Canaccord news, you can click here:
more Canaccord newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Smart Score. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest TipRanks news, Best Stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
TipRanks platformTipRanks
•74% Informative
TipRanks’ Smart Score offers an impartial and data-driven approach to investing.
The Smart Score uses data to give every stock a simple rating, on a score of 1 to 10 , based on a group of factors that are proven to line up with future outperformance.
When the Smart Score aligns with Wall Street analyst recommendations, it signals a strong, bullish opportunity for investors.
AngioDynamics is a medical device maker offering medical devices aimed at multiple medical specialty fields.
The devices are used to diagnose various cancers as well as peripheral vascular disease, and are designed to minimize invasive operations.
The company reported revenue of $70.98 million , a 22% year-over-year decline, yet still managed to surpass estimates by $ 120,000 .
Canaccord Genuity analyst John Young puts a Buy rating on ANGO shares, with a price target of $ 13.33 .
VR Score
74
Informative language
75
Neutral language
57
Article tone
semi-formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
1
Affiliate links
no affiliate links